Merck & Co. MRK shares traded lower on Tuesday, tracking a broader market downturn as major indices slipped into the red. The ...

Merck stock performance snapshot Merck (MRK) has drawn fresh attention after recent trading left the shares at a last close ...

In March, Merck & Co Inc. MRK agreed to acquire Terns Pharmaceuticals Inc. TERN, as the U.S. drugmaker accelerates efforts to ...

Merck & Co., Inc. (NYSE:MRK) is included among the 15 Best Consistent Dividend Stocks to Buy Right Now. On April 6, JPMorgan ...

Merck (MRK) stock achieved a 5-day winning streak, with total gains during this time reaching 6.9%. The company’s market capitalization has jumped by approximately $17 billion over the past five days, ...

Merck MRK stock has declined 4% since it announced second-quarter results on July 29 before market open. While the company’s earnings beat estimates, its sales came in line. Earnings of $2.13 per ...

Cidara Therapeutics, Inc. is being acquired by Merck for ~$9.2bn ($221.5/share) after strong results for its lead antiviral CD388. CD388, a broad-spectrum influenza prophylactic, demonstrated robust ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over the ...